Lizama BN, North HA, Pandey K, Williams C, et al. An interim exploratory proteomics biomarker analysis of a phase 2 clinical trial to assess the impact of CT1812 in Alzheimer's disease. Neurobiol Dis 2024 Jun 22:106575. doi: 10.1016/j.nbd.2024.106575.
PMID: 38914170